Advertisement

Topics

Medivir begins phase I/II study of birinapant in combo with Keytruda in patients with treatment─refractory solid tumours

09:51 EDT 21 Aug 2017 | PharmaBiz

Medivir AB has announces that the first patient has been enrolled in the company's phase I/II study of birinapant in combination with the anti─PD─1 therapy Keytruda (pembrolizumab), which is marketed by MSD

Original Article: Medivir begins phase I/II study of birinapant in combo with Keytruda in patients with treatment─refractory solid tumours

NEXT ARTICLE

More From BioPortfolio on "Medivir begins phase I/II study of birinapant in combo with Keytruda in patients with treatment─refractory solid tumours"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...